Login to Your Account



MedImmune's Intranasal Vaccine FluMist Receives FDA Approval

By Aaron Lorenzo


Wednesday, June 18, 2003
MedImmune Inc. received long-awaited news late Tuesday afternoon as the FDA approved FluMist, a nasally delivered product that has ridden a rocky road throughout the regulatory review process. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription